Repligen Buy Hold or Sell Recommendation

RGEN -- USA Stock  

USD 57.30  1.78  3.01%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Repligen Corporation is 'Strong Buy'. Macroaxis provides Repligen buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Repligen positions. The advice algorithm takes into account all of Repligen available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Repligen buy-and-hold prospective. Additionally take a look at Repligen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell RepligenBuy Repligen
Strong Buy

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

Inapplicable
For the selected time horizon Repligen Corporation has a risk adjusted performance of 0.0797, jensen alpha of 0.2591, total risk alpha of 0.4954, sortino ratio of 0.1154 and treynor ratio of 0.2957
Macroaxis advice module provides unbiased recommendation that can be used to complement current average analyst sentiment on Repligen. Our advice engine ##verb4## current market data to analyse the company potential to grow from the prospective of investors risk tolerance and investing horizon. To make sure Repligen is not overpriced, please check all Repligen fundamentals including its Revenue, Cash Flow from Operations, Current Asset, as well as the relationship between Cash per Share and Beta . Given that Repligen has Number of Shares Shorted of 4.95M, we recommend you check out Repligen market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

Repligen Thematic Classifications

Biotech IdeaBiotech
Biotechnology and pharmaceuticals production and services

Repligen Returns Distribution Density

Mean Return0.20Value At Risk3.62
Potential Upside4.20Standard Deviation3.43
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Blackrock IncCommon Shares6.2 M344.6 M
Vanguard Group IncCommon Shares3.9 M217.6 M
Invesco LtdCommon Shares2.3 M128.4 M
Oppenheimerfunds IncCommon Shares2.2 M124.2 M
Conestoga Capital Advisors LlcCommon Shares1.9 M107.7 M
State Street CorpCommon Shares1.8 M101.5 M
Wellington Management Group LlpCommon Shares1.4 M80.2 M
Polygon Management LtdDebt20 M35.7 M

Repligen Greeks

α
Alpha over DOW
=0.26
β
Beta against DOW=0.63
σ
Overall volatility
=3.38
Ir
Information ratio =0.09

Repligen Volatility Alert

Repligen Corporation currently demonstrates below average downside deviation of 2.62. It has Information Ratio of 0.09 and Jensen Alpha of 0.26. However, we do advice investors to further question Repligen Corporation expected returns to make sure all indicators are consistent with the current outlook about its relatively low value at risk.
    
 Better Than Average     
    
 Worse Than Average Compare Repligen to competition

Repligen Fundamental Vs Peers

FundamentalsRepligenPeer Average
Return On Equity3.91% (15.17)%
Return On Asset2.73% (15.64)%
Profit Margin12.61% (5.50)%
Operating Margin26.48% (10.91)%
Current Valuation2.6B152.14B
Shares Outstanding43.86M1.43B
Shares Owned by Insiders11.31% 6.91%
Shares Owned by Institutions96.65% 18.37%
Number of Shares Shorted4.95M3.24M
Price to Earning121.29X40.69X
Price to Book4.47X14.44X
Price to Sales14.77X17.81X
Revenue183.7M9.85B
Gross Profit78M21.75B
EBITDA48.64M1.41B
Net Income23.16M517.71M
Cash and Equivalents190.3M3.89B
Cash per Share4.34X5.17X
Total Debt102.4M7.36B
Debt to Equity16.80% 0.72%
Current Ratio2.06X3.30X
Book Value Per Share13.83X13.64X
Cash Flow from Operations33.25M1.25B
Short Ratio8.02X2.09X
Earnings Per Share0.51X2.30X
Price to Earnings To Growth3.47X1.22X
Number of Employees47610.67K
Beta0.820.34
Market Capitalization2.71B29.78B
Total Asset146.24M126.86B
Retained Earnings(140.42M)38.24B
Working Capital84.47M3.58B
Current Asset103.25M36.8B
   Exercise or conversion by Jon Snodgres of 10253 shares of Repligen subject to Rule 16b-3 [view details]

Repligen Market Momentum

Repligen Alerts

Trading Alerts and Improvement Suggestions

Repligen has very high historical volatility over the last 30 days
Over 97.0% of the company shares are owned by institutional investors

Latest Analysts View

Repligen Current Analysts Recommendations

Target Median Price65.00
Target Mean Price66.00
Recommendation Mean1.80
Target High Price75.00
Number Of Analyst Opinions9
Target Low Price55.00
Additionally take a look at Repligen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Cryptocurrency Arbitrage module to find pairs of digital assets on multiple exchanges that are traded at a risk free arbitrage.
Search macroaxis.com